TOP2A and cancer: The human TOP2 proteins, TOP2A and an isomer TOP2B, are the targets for several anti‐cancer agents64, 131 including etoposide, intercalating anthracyclines (doxorubicin and daunorubicin) and the anthraquinone MTX.132